The FDA Oncology Center of Excellence is holding a workshop Nov. 27 to teach cancer patient advocates about the FDA's mission of ensuring access to safe and effective treatments, writes Paul Kluetz, acting associate director of patient outcomes at the center. Topics include cancer treatment diagnosis, development, drugs and devices; the role of patient advocates in supporting the FDA's mission; and clinical trial endpoint terminology.
Sign up for FasterCures SmartBrief
Medical research news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.